Anticonvulsant profile and teratogenicity of 3,3-dimethylbutanoylurea: A potential for a second generation drug to valproic acid

Jakob Avi Shimshoni, Boris Yagen, Neta Pessah, Bogdan Wlodarczyk, Richard H. Finnell, Meir Bialer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Purpose: The purpose of this study was to evaluate the anticonvulsant activity and teratogenic potential of branched aliphatic acylureas represented by isovaleroylurea (IVU), pivaloylurea (PVU) and 3,3-dimethylbutanoylurea (DBU), as potential second-generation drugs to valproic acid (VPA). Methods: The anticonvulsant activity of IVU, PVU, and DBU was determined in mice and rats utilizing the maximal electroshock seizure (MES) and the pentylenetetrazole (scMet) tests. The ability of DBU to block electrical-, or chemical-induced seizures was further examined in three acute seizure models: the psychomotor 6 Hz model, the bicuculline and picrotoxin models and one model of chronic epilepsy (i.e., the hippocampal kindled rat model). The induction of neural tube defects (NTDs) by IVU, PVU, and DBU was evaluated after i.p. administration at day 8.5 of gestation to a mouse strain highly susceptible to VPA-induced teratogenicity. The pharmacokinetics of DBU was studied following i.v. administration to rats. Results: DBU emerged as the most potent compound having an MES-ED50 of 186 mg/kg (mice) and 64 mg/kg (rats) and an scMet-ED50 of 66 mg/kg (mice) and 26 mg/kg (rats). DBU underwent further evaluation in the hippocampal kindled rat (ED50 = 35 mg/kg), the psychomotor 6 Hz mouse model (ED50 = 80 mg/kg at 32 mA and ED50 = 133 mg/kg at 44 mA), the bicuculline- and picrotoxin-induced seizure mouse model (ED50 = 205 mg/kg and 167 mg/kg, respectively). In contrast to VPA, DBU, IVU, and PVU did not induce a significant increase in NTDs as compared to control. DBU was eliminated by metabolism with a half-life of 4.5 h. Conclusions: DBU's broad spectrum and potent anticonvulsant activity, along with its high safety margin and favorable pharmacokinetic profile, make it an attractive candidate to become a new, potent, and safe AED.

Original languageEnglish
Pages (from-to)1202-1212
Number of pages11
JournalEpilepsia
Volume49
Issue number7
DOIs
StatePublished - Jul 2008

Keywords

  • Anticonvulsants
  • Maximal electroshock seizure test
  • Pharmacokinetics
  • Subcutaneous pentylentetrazole seizure test
  • Teratogenicity

Fingerprint

Dive into the research topics of 'Anticonvulsant profile and teratogenicity of 3,3-dimethylbutanoylurea: A potential for a second generation drug to valproic acid'. Together they form a unique fingerprint.

Cite this